Edap Tms’ (EDAP) “Hold” Rating Reiterated at Jefferies Financial Group

Jefferies Financial Group reiterated their hold rating on shares of Edap Tms (NASDAQ:EDAP) in a research note published on Friday, MarketBeat.com reports. The brokerage currently has a $2.00 target price on the medical equipment provider’s stock, down from their prior target price of $8.00.

Several other analysts have also recently issued reports on EDAP. Piper Sandler lowered their price objective on shares of Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a research note on Friday, March 28th. StockNews.com assumed coverage on shares of Edap Tms in a research note on Friday, March 28th. They set a “hold” rating for the company. Finally, HC Wainwright restated a “buy” rating and set a $19.00 target price on shares of Edap Tms in a report on Friday, March 28th.

Edap Tms Price Performance

EDAP stock opened at $1.61 on Friday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.46 and a current ratio of 2.18. The stock’s 50 day moving average price is $2.39 and its 200 day moving average price is $2.45. The firm has a market cap of $59.74 million, a P/E ratio of -2.48 and a beta of 0.37. Edap Tms has a 1 year low of $1.51 and a 1 year high of $8.50.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06. The business had revenue of $22.69 million during the quarter, compared to the consensus estimate of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. On average, sell-side analysts expect that Edap Tms will post -0.6 earnings per share for the current fiscal year.

Institutional Trading of Edap Tms

Several institutional investors and hedge funds have recently bought and sold shares of EDAP. Jane Street Group LLC grew its holdings in shares of Edap Tms by 174.7% during the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock valued at $69,000 after purchasing an additional 73,361 shares during the last quarter. Schonfeld Strategic Advisors LLC lifted its holdings in Edap Tms by 48.5% in the fourth quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock worth $355,000 after purchasing an additional 52,500 shares during the period. Millennium Management LLC lifted its stake in shares of Edap Tms by 218.5% in the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after acquiring an additional 33,558 shares during the period. BNP Paribas Financial Markets increased its stake in shares of Edap Tms by 111.5% during the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 25,650 shares during the period. Finally, Rock Springs Capital Management LP lifted its position in Edap Tms by 1.5% in the fourth quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock worth $3,518,000 after purchasing an additional 23,800 shares during the period. Institutional investors and hedge funds own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.